1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow gancotamab: new trials by email Literature Review of gancotamab trials Research Report on gancotamab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients MM-302, Gemcitabine, Capecitabine - Breast Cancer, HER2 Positive Breast Cancer | Phase 2 / Phase 3 | Terminated | Merrimack Pharmaceuticals | 113 | 2014-07-01 | 2017-01-06 |
Breast Neoplasms (1)
Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Spain (1) · United States (1)